Abstract

Plasticity of melanoma and EMT-TF reprogramming

Highlights

  • Epithelial-mesenchymal transition (EMT) is a reversible embryonic genetic program reactivated in cancer

  • We addressed the interrelationship between EMTTF network and tumour-initiating pathways in malignant melanoma [4]

  • Melanoma represents an example of a cancer type solely dependent on the oncogenic pathways initiated by gain-of function mutations in BRAF, NRAS, GRM3 or MEK1/2 with all of them leading to the activation of MEK-ERK module

Read more

Summary

Introduction

Epithelial-mesenchymal transition (EMT) is a reversible embryonic genetic program reactivated in cancer. Melanoma represents an example of a cancer type solely dependent on the oncogenic pathways initiated by gain-of function mutations in BRAF, NRAS, GRM3 or MEK1/2 with all of them leading to the activation of MEK-ERK module. In vitro activation of the MEK-ERK signalling results in the reversion of EMT-TF expression pattern, the downregulation of SNAIL2 and ZEB2 and upregulation of ZEB1/TWIST1.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call